​

Adagio Medical Stock (NASDAQ:ADGM)

OwnershipFinancialsChart
Adagio Medical by TradingView

Previous Close

$0.75

52W Range

$0.70 - $2.58

50D Avg

$1.06

200D Avg

$1.17

Market Cap

$11.47M

Avg Vol (3M)

$144.67K

Beta

-0.19

Div Yield

-

ADGM Company Profile

Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

80

IPO Date

Jul 23, 2024

Website

ADGM Performance

ADGM Financial Summary

Dec 25Dec 24Dec 23
Revenue-$269.00K$300.00K
Operating Income$-21.89M$-62.48M$-27.94M
Net Income$-25.08M$-53.76M$-38.15M
EBITDA$-21.89M$-62.48M$-27.41M
Basic EPS$-1.51$-3.54$-4.86
Diluted EPS$-1.51$-3.54$-4.86

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
COCHEnvoy Medical, Inc.
IRIXIRIDEX Corporation
ALURAllurion Technologies Inc.
ATHAAthira Pharma, Inc.
CODXCo-Diagnostics, Inc.
VVOSVivos Therapeutics, Inc.
LPTXLeap Therapeutics, Inc.
VSEEVSee Health, Inc.
NVNOenVVeno Medical Corporation
CTXRCitius Pharmaceuticals, Inc.